Abstract
The rationale for the objective assessment of dose‐response curves (DRCs) is presented. Using data derived from isoprenaline/heart rate responses studies, two new statistical methods of objectively defining the terminal linear segment of an incomplete DRC are presented. Using data derived from phenylephrine/diastolic blood pressure response studies, the parallel shift quadratic model of Sumner et al. (1982) has been extended to include a measure of the suitability of the quadratic model for each individual data set using the Akaike information criterion. A parallel shift Emax model is proposed for complete DRCs. 1987 The British Pharmacological Society
Original language | English (US) |
---|---|
Pages (from-to) | 199-205 |
Number of pages | 7 |
Journal | British Journal of Clinical Pharmacology |
Volume | 23 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1987 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology (medical)
- Pharmacology